THE DEMOGRAPHICS OF ATYPICAL AND IDIOPAHTIC SLIPPED CAPITAL FEMORAL EPIPHYSIS: IMPLICATIONS FOR FURTHER DIAGNOSITC INVESTIGATION AND THE DESCRIPTION OF THE AGE-WEIGHT TEST (AWT)

 

Participants: R.T. Loder, M.L.V.H. Greenfield

Keywords: slipped capital femoral epiphysis, radiation therapy, renal failure, endocrine disorder, age, weight, age-weight test

Introduction

Slipped capital femoral epiphysis (SCFE) is a well-known adolescent hip disorder that may be classified as atypical or idiopathic. Atypical SCFEs (1) are those associated with endocrine disorders (2, 3) with other metabolic disorders such as renal failure osteodystrophy (4, 5, 6), or with radiation therapy for malignancies in the pelvic areas (7, 8). While the majority of SCFEs are idiopathic (9), a differential diagnosis regarding the underlying etiology should be considered when the physician encounters a newly diagnosed case of SCFE.

If it is present, the parents or patient will generally give a pre-existing history of radiation therapy. However, SCFE may be the initial presentation a metabolic disorder. In this latter situation the clinician must decide whether further diagnostic work-up is indicated. Such a work-up is important, not only to diagnose and treat the underlying medical condition, but also to anticipate and minimize anesthetic problems during surgery (10, 11). Anesthetic problems, which stem from the underlying metabolic disorder, may be potentially fatal to the patient (11). Some clinicians recommend an aggressive approach to further work-up (3). However, in this era of health care cost containment, the luxury of such an approach is not always possible.

The purpose of this study was to investigate demographic variables of both idiopathic and atypical SCFE to determine when further evaluation is warranted.

Materials and Methods

The demographic variables of 433 children with 612 SCFEs was compile and divided into 4 subgroups: I—idiopathic (ID), II—renal failure (RFA), III—radiation therapy (RTA), and IV—endocrine disorders (ENDA). Statistical analyses consisted of univariate, bivariate, and stepwise forward multiple logistic regression.

Results

There were 285 ID, 31 RTA, and 85 ENDA children. Logistic regression analysis demonstrated that both age and weight percentile groups were predictive of an atypical SCFE: age less than 10 years or greater than 16 years (p = 0.0003, OR 4.2, 95%CI 1.9, 9.3) and weight less than the 50th percentile (p < 0.0001, OR 8.4, (95%CI 3.8, 18.4).

That is, at the time of initial presentation both age and weight were predictive of a patient having an atypical SCFE. For two patients of equal weights, those less than 10 years old or greater than 16 years old are 4.2 time more likely to have an atypical SCFE; for two patients of equal age, the one who weight falls in the 50th percentile or less is 8.4 times more likely to have an atypical SCFE.

On the basis of this information, we defined the age-weight test (AWT) to help predict the idiopathic or atypical nature of a SCFE.

  Age < 16 years Age > 16 years
Weight > 50th percentile AWT (-) AWT (+)
Weight < 50th percentile AWT (+) AWT (+)

This AWT has a negative predictive value of 93%; the chance of a child with a negative AWT having an idiopathic SCFE is 93%. The positive predictive value is 52%; the chance of a child with a positive AWT having an atypical SCFE is 52%.

Conclusion

Further clinical investigation into the etiology of the SCFE should be considered for any child with a positive AWT.

References

  1.  
  2. McAfee PC, Cady RB. Endocrinologic and metabolic factors in atypical presentation of slipped capital femoral epiphysis. Clin Orthop 180:188-197, 1983.
  3.  
  4. Loder RT, Wittenberg B, Desilva G. Slipped capital femoral epiphysis associated with endocrine disorders. J Pediatr Orthop 15:349-356, 1995.
  5.  
  6. Wells D, King JD, Roe TF, Kaufman FR. Review of slipped capital femoral epiphysis associated with endocrine disease. J Pediatr Orthop 13:610-614. 1993
  7.  
  8. Apel DM, Millar EA, Moel DI. Skeletal disorders in a pediatric renal transplant population. J Pediatr Orthop 9:505-511, 1989.
  9.  
  10. Loder RT, Hensinger RN. Slipped capital femoral epiphysis associated with renal failure osteodystrophy. J Pediatr Orthop 17:205-211, 1997.
  11.  
  12. Nixon JR, Douglas JF. Bilateral slipping of the upper femoral epiphysis in end-stage renal failure. A report of two cases. J Bone Joint Surg 62-B:18-21, 1980.
  13.  
  14. Barrett IR. Slipped capital femoral epiphysis following radiotherapy. J Pediatr Orthop 5:268-273, 1985.
  15.  
  16. Loder RT, Hensinger RN, Alburger PD, Aronsson DD, Beaty JH, Roy DR, Stanton RP, Turker R. Slipped capital femoral epiphysis associated with radiation therapy. J Pediatr Orthop 18:630-636, 1998.
  17.  
  18. Mann DC, Weddington J, Richton S. Hormonal studies in patients with slipped capital femoral epiphysis without evidence of endocrinopathy. J Pediatr Orthop 8:543-545, 1988.
  19.  
  20. Roizen MF. Anestheic implications of concurrent diseases. In: Miller RD, ed. Anesthesia, 4th ed., New York: Churchill Livingstone. 903-1014, 1994.
  21.  
  22. Saltzman CL, Herzenberg JE, Phillips WA, Hensinger RN, Hopwood NJ. Thick lips, bumpy tongue, and slipped capital femoral epiphysis—a deadly combination. J Pediatr Orthop 8:219-222, 1988.